Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New antihypertensive agents from Banyu

Dec. 16, 1996

Distamycin analogues claimed by Mitsui Toatsu

Dec. 16, 1996

Antihypertensive peptides disclosed by Snow Brand

Dec. 13, 1996

New immunostimulant from Snow Brand

Dec. 13, 1996

Chugai reports new cholesterol-lowering compounds

Dec. 13, 1996

Abbott reports on new PAF antagonists

Dec. 13, 1996

Novel 5-HT4 receptor agonist claimed by Pharmacia & Upjohn

Dec. 13, 1996

NK1 antagonists described by Boehringer Ingelheim

Dec. 13, 1996

Roussel Uclaf reports new quinoline derivatives

Dec. 13, 1996

Therapeutically active cysteine proteinase inhibitors described by Synphar

Dec. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.